Currently predicting for Thu, 4 Jun 2026

RLYB Prediction Chart

RLYB Predictions History

Latest community submissions for RLYB.
Predictor Target Session Target Price Result Direction Accuracy Score
Sep 5, 2025 $0.564 -87.96% $0.609 V 92.72% 0
Sep 5, 2025 $0.572 -87.79% $0.609 V 94.06% 0
Sep 5, 2025 Bullish $0.609 X 1
Jul 9, 2025 $0.499 -87.81% $0.446 V 88.31% 1
Jul 9, 2025 $5.00 +22.21% $0.446 X 0.00% 0
Jun 4, 2024 $1.61 -87.01% $1.55 X 96.06% 0
Jun 4, 2024 $1.59 -87.19% $1.55 X 97.54% 0
Jun 4, 2024 Bearish $1.55 V 0
JS JS Pro
Jul 7, 2023 $5.74 -87.80% $5.23 V 90.25% 1
Jul 7, 2023 $5.64 -88.01% $5.23 V 92.13% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for RLYB with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT RALLYBIO CORPORATION
Rallybio
Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT). The company is also developing RLYB211, a polyclona...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE